Zota Health Care Limited (NSE: ZOTA)
India
· Delayed Price · Currency is INR 838.60
+10.90 (1.32%)
Dec 26, 2024, 1:47 PM IST
Zota Health Care Income Statement
Financials in millions INR. Fiscal year is April - March.
Millions INR. Fiscal year is Apr - Mar.
Fiscal Year | TTM | FY 2024 | FY 2023 | FY 2022 | FY 2021 | FY 2020 | 2019 - 2015 |
|---|---|---|---|---|---|---|---|
Period Ending | Sep '24 Sep 30, 2024 | Mar '24 Mar 31, 2024 | Mar '23 Mar 31, 2023 | Mar '22 Mar 31, 2022 | Mar '21 Mar 31, 2021 | Mar '20 Mar 31, 2020 | 2019 - 2015 |
| Operating Revenue | 2,201 | 1,805 | 1,400 | 1,312 | 1,068 | 951.13 | Upgrade
|
| Other Revenue | - | - | 7.94 | 0.77 | 3.98 | 0.66 | Upgrade
|
| Revenue | 2,201 | 1,805 | 1,408 | 1,313 | 1,072 | 951.79 | Upgrade
|
| Revenue Growth (YoY) | 40.64% | 28.23% | 7.22% | 22.47% | 12.62% | 11.15% | Upgrade
|
| Cost of Revenue | 1,062 | 971.65 | 835.11 | 867.29 | 733.65 | 664.21 | Upgrade
|
| Gross Profit | 1,139 | 833.24 | 572.41 | 445.41 | 338.21 | 287.58 | Upgrade
|
| Selling, General & Admin | 629.06 | 371.74 | 212.65 | 159.4 | 216.07 | 144.67 | Upgrade
|
| Other Operating Expenses | 512.95 | 385.95 | 278.46 | 137.26 | 111.75 | 96.61 | Upgrade
|
| Operating Expenses | 1,436 | 958.55 | 610.68 | 333.37 | 359.5 | 262.25 | Upgrade
|
| Operating Income | -296.95 | -125.31 | -38.27 | 112.05 | -21.29 | 25.32 | Upgrade
|
| Interest Expense | -79.82 | -41.99 | -24.86 | -2.58 | -0.5 | -0.14 | Upgrade
|
| Interest & Investment Income | 9.48 | 9.48 | 8.82 | 13.16 | 7.2 | 10.49 | Upgrade
|
| Currency Exchange Gain (Loss) | 1.94 | 1.94 | 2.37 | 2.3 | 1.15 | 3.49 | Upgrade
|
| Other Non Operating Income (Expenses) | -5.63 | -5.76 | -0.36 | -0.58 | -0.5 | -0.55 | Upgrade
|
| EBT Excluding Unusual Items | -370.97 | -161.63 | -52.29 | 124.35 | -13.94 | 38.62 | Upgrade
|
| Other Unusual Items | - | - | 5.38 | - | 10.29 | - | Upgrade
|
| Pretax Income | -370.97 | -161.63 | -46.91 | 124.35 | -3.65 | 38.62 | Upgrade
|
| Income Tax Expense | -23.36 | -18.15 | 10.82 | 35.27 | -1.57 | 11.2 | Upgrade
|
| Net Income | -346.82 | -143.48 | -57.73 | 89.08 | -2.09 | 27.42 | Upgrade
|
| Net Income to Common | -346.82 | -143.48 | -57.73 | 89.08 | -2.09 | 27.42 | Upgrade
|
| Net Income Growth | - | - | - | - | - | -50.59% | Upgrade
|
| Shares Outstanding (Basic) | 26 | 26 | 25 | 25 | 25 | 25 | Upgrade
|
| Shares Outstanding (Diluted) | 26 | 26 | 25 | 25 | 25 | 25 | Upgrade
|
| Shares Change (YoY) | 12.61% | 1.92% | 1.11% | 1.32% | - | - | Upgrade
|
| EPS (Basic) | -13.23 | -5.59 | -2.29 | 3.58 | -0.09 | 1.12 | Upgrade
|
| EPS (Diluted) | -13.23 | -5.59 | -2.29 | 3.58 | -0.09 | 1.12 | Upgrade
|
| EPS Growth | - | - | - | - | - | -50.59% | Upgrade
|
| Free Cash Flow | -466.42 | -226.94 | -145.05 | 100.84 | -28.18 | 47.31 | Upgrade
|
| Free Cash Flow Per Share | -17.79 | -8.85 | -5.77 | 4.05 | -1.15 | 1.93 | Upgrade
|
| Dividend Per Share | - | 1.000 | 1.000 | 1.500 | 1.000 | 1.000 | Upgrade
|
| Dividend Growth | - | 0% | -33.33% | 50.00% | 0% | 40.00% | Upgrade
|
| Gross Margin | 51.75% | 46.17% | 40.67% | 33.93% | 31.55% | 30.21% | Upgrade
|
| Operating Margin | -13.49% | -6.94% | -2.72% | 8.54% | -1.99% | 2.66% | Upgrade
|
| Profit Margin | -15.75% | -7.95% | -4.10% | 6.79% | -0.19% | 2.88% | Upgrade
|
| Free Cash Flow Margin | -21.19% | -12.57% | -10.31% | 7.68% | -2.63% | 4.97% | Upgrade
|
| EBITDA | -141.45 | -63.1 | 2.83 | 140.75 | 9.61 | 45.91 | Upgrade
|
| EBITDA Margin | -6.43% | -3.50% | 0.20% | 10.72% | 0.90% | 4.82% | Upgrade
|
| D&A For EBITDA | 155.49 | 62.21 | 41.1 | 28.7 | 30.9 | 20.59 | Upgrade
|
| EBIT | -296.95 | -125.31 | -38.27 | 112.05 | -21.29 | 25.32 | Upgrade
|
| EBIT Margin | -13.49% | -6.94% | -2.72% | 8.54% | -1.99% | 2.66% | Upgrade
|
| Effective Tax Rate | - | - | - | 28.37% | - | 29.00% | Upgrade
|
| Revenue as Reported | - | 1,816 | 1,419 | 1,328 | 1,080 | 966.26 | Upgrade
|
| Advertising Expenses | - | 62.27 | 78.95 | 50.1 | 115.31 | 32.27 | Upgrade
|
Source: S&P Capital IQ. Standard template. Financial Sources.